The effectiveness and safety of beta antagonist in burned patients: A systematic review and meta‐analysis

Beta antagonist is one of the most effective and the least toxic pharmacological treatments to attenuate the raised catecholamine effects for burned patients. To evaluate the effectiveness and safety of beta blocker compared with placebo or usual care in burned patients, a meta‐analysis of randomised controlled trials (RCTs) was conducted. We searched the database of PubMed, Embase, the Cochrane Library, and Web of Science to 10 April 2020. Two investigators independently assessed articles for inclusion and exclusion criteria and selected studies for the final analysis. We performed the meta‐analysis using a random‐effect model. A total of 12 RCTs were included in the study, including 1887 patients. Propranolol‐treated patients have a decrease in length of hospital stay in adults (weighted mean difference [WMD] = −9.06, 95% CIs = [−12.88, −5.24]) and prepare time of graft (WMD = −7.88, 95% CIs = [−12.27, −3.50]). Similarly, the use of propranolol could significantly decrease heart rate (WMD = −15.16, 95% CIs = [−20.37, −9.94]), rate pressure product (WMD = −1.32, 95% CIs = [−1.67, −0.97]), and mean arterial pressure (WMD = −2.75, 95% CIs = [−4.23, −1.26]). Moreover, there is no significant difference between propranolol and placebo with respect to mortality (risk difference [RD] = 0.00, 95% CIs [−0.03, 0.04]), sepsis (RD = −0.03, 95% CIs [−0.09, 0.03]), and events of post‐traumatic stress disorder (PTSD) and acute stress disorder (RD = −0.01, 95% CIs [−0.07, 0.05]), and also, there is no significant difference in subgroup analysis based on age. The use of beta antagonist in burned patients does reduce length of hospital stay in adults, shorten the preparation time for graft, and reduce heart burden, without increasing mortality, sepsis, or PTSD compared with those who had usual care or placebo. So beta antagonist can be considered as an appropriate treatment strategy in burned patients. More prospective, randomised‐controlled, multi‐centre studies were needed to define their place in therapeutic algorithms.

[1]  J. Kenardy,et al.  Preventive intervention for trauma reactions in young injured children: results of a multi-site randomised controlled trial. , 2020, Journal of child psychology and psychiatry, and allied disciplines.

[2]  S. Cheema,et al.  Effects of Propranolol in Accelerating Wound Healing and Attenuation of Hypermetabolism in Adult Burn Patients. , 2020, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[3]  D. Herndon,et al.  Does Acute Propranolol Treatment Prevent Posttraumatic Stress Disorder, Anxiety, and Depression in Children with Burns? , 2017, Journal of child and adolescent psychopharmacology.

[4]  M. Byrnes,et al.  Quality of life and posttraumatic growth after adult burn: A prospective, longitudinal study. , 2017, Burns : journal of the International Society for Burn Injuries.

[5]  P. Ferrada,et al.  Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis , 2017, World Journal of Emergency Surgery.

[6]  C. Andersen,et al.  Propranolol Reduces Cardiac Index But does not Adversely Affect Peripheral Perfusion in Severely Burned Children , 2016, Shock.

[7]  Mark B. Powers,et al.  Psychometric properties of the Posttraumatic Stress Disorder Symptom Scale Interview for DSM-5 (PSSI-5). , 2016, Psychological assessment.

[8]  C. Andersen,et al.  Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children , 2016, Annals of surgery.

[9]  J. Paratz,et al.  The efficacy and safety of adrenergic blockade after burn injury: A systematic review and meta-analysis , 2016, The journal of trauma and acute care surgery.

[10]  J. H. Lee,et al.  Do β-Blockers Decrease the Hypermetabolic State in Critically Ill Children With Severe Burns? , 2015, Hospital pediatrics.

[11]  C. Andersen,et al.  Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults , 2015, Critical Care.

[12]  Sean M. Randall,et al.  Long-term mortality among older adults with burn injury: a population-based study in Australia , 2015, Bulletin of the World Health Organization.

[13]  B. Cairns,et al.  Results of a Pilot Multicenter Genotype-based Randomized Placebo-controlled Trial of Propranolol to Reduce Pain After Major Thermal Burn Injury , 2015, The Clinical journal of pain.

[14]  R. Gamelli,et al.  American Burn Association consensus statements. , 2013 .

[15]  R. Gamelli,et al.  Summary of the 2012 ABA Burn Quality Consensus Conference , 2013, Journal of burn care & research : official publication of the American Burn Association.

[16]  R. Barrow,et al.  Long-Term Propranolol Use in Severely Burned Pediatric Patients: A Randomized Controlled Study , 2012, Annals of surgery.

[17]  Kenneth J Sher,et al.  The structure of Diagnostic and Statistical Manual of Mental Disorders (4th edition, text revision) personality disorder symptoms in a large national sample. , 2012, Personality disorders.

[18]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[19]  A. Mohammadi,et al.  Efficacy of Propranolol in Wound Healing for Hospitalized Burn Patients , 2009, Journal of burn care & research : official publication of the American Burn Association.

[20]  D. Herndon,et al.  Metabolism modulators in sepsis: Propranolol , 2007, Critical care medicine.

[21]  D. Herndon,et al.  Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. , 2007, The Journal of trauma.

[22]  Andrea M A Costa,et al.  BLOCKADE OF β1‐ AND β2‐ADRENOCEPTORS DELAYS WOUND CONTRACTION AND RE‐EPITHELIALIZATION IN RATS , 2006 .

[23]  D. Patterson,et al.  Psychosocial aspects of burn injuries , 2004, BMJ : British Medical Journal.

[24]  R. Tompkins,et al.  Support of the metabolic response to burn injury , 2004, The Lancet.

[25]  S. Lal,et al.  β-blockade and growth hormone after burn , 2002 .

[26]  D. Chinkes,et al.  Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.

[27]  R. Demling,et al.  ANTICATABOLIC AND ANABOLIC STRATEGIES IN CRITICAL ILLNESS: A REVIEW OF CURRENT TREATMENT MODALITIES , 1998, Shock.

[28]  R. Barrow,et al.  Prolonged use of propranolol safely decreases cardiac work in burned children. , 1997, The Journal of burn care & rehabilitation.

[29]  A. Wallace,et al.  Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.

[30]  T. Patterson,et al.  Behavioural factors in burn mortality and length of stay in hospital , 1984 .

[31]  A. Mason,et al.  Catecholamines: Znediator of the Hypermetabolic Response to Thermal Injury , 1974, Annals of surgery.

[32]  Y. Wang,et al.  Hemodynamic correlates of myocardial oxygen consumption during upright exercise. , 1972, Journal of applied physiology.

[33]  L. Katz,et al.  The Relation of Cardiac Effort to Myocardial Oxygen Consumption and Coronary Flow , 1958, Circulation research.

[34]  P. Maitz,et al.  Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring , 2018, Advanced drug delivery reviews.

[35]  W. Meyer,et al.  Propranolol does not reduce risk for acute stress disorder in pediatric burn trauma. , 2010, The Journal of trauma.

[36]  José Luis Alfonso Sánchez,et al.  Cost-utility analysis applied to the treatment of burn patients in a specialized center. , 2007, Archives of surgery.

[37]  S. Lal,et al.  Beta-blockade and growth hormone after burn. , 2002, Annals of surgery.